The Ending Eclampsia Project seeks to increase access to quality, underutilized interventions and commodities for the prevention, detection, and management of pre-eclampsia and eclampsia (PE/E), including promoting correct use of antihypertensive drugs and magnesium sulphate (MgSO4). This final report details the findings of a qualitative study that explored health system bottlenecks that prevent access to quality maternal and newborn health care in two Kenyan counties, Kakamega and Kitui, with a specific focus on PE/E. The study explored policy implementation gaps in Kenya’s newly devolved county government structure, to:1) assess the policy and health system environment for PE/E diagnosis, referral, and treatment, including potential supply-chain bottlenecks, 2) investigate similarities and differences in PE/E knowledge, attitudes, and care-seeking behaviors among providers, women, and community members, and 3) generate lessons for scaling up proven underutilized PE/E interventions more effectively. A desk review of relevant Kenyan policies was conducted in addition to eight focus group discussions and 114 in-depth interviews with policymakers and program implementers.
Ndwiga, Charity, Pooja Sripad, and Charlotte E. Warren. 2018. "Addressing barriers to quality of underutilized commodities and services for prevention and management of pre-eclampsia and eclampsia in Kenya," Ending Eclampsia Final Study Report. Washington, DC: Population Council.